![]() |
市場調査レポート
商品コード
1304504
短鎖フラクトオリゴ糖(scFOS)の世界市場-2023年~2030年Global Short-chain Fructooligosaccharides (scFOS) Market - 2023-2030 |
||||||
カスタマイズ可能
適宜更新あり
|
短鎖フラクトオリゴ糖(scFOS)の世界市場-2023年~2030年 |
出版日: 2023年07月07日
発行: DataM Intelligence
ページ情報: 英文 200 Pages
納期: 即日から翌営業日
|
短鎖フラクトオリゴ糖(scFOS)の世界市場は、2022年に5億7,050万米ドルに達し、2030年には12億3,180万米ドルに達し、有利な成長が予測されています。予測期間2023-2030年のCAGRは10.1%です。
消化器系の健康は、全体的な健康状態における腸内細菌叢の役割に対する認識が高まるにつれて、消費者の重要な関心分野となっています。ScFOSはプレバイオティクスとして、有益な腸内細菌に栄養を与え成長を促進し、健康的な腸内細菌叢の構成をサポートします。ScFOSは、腸の健康を促進する有益な細菌であるプロバイオティクスの栄養源として機能します。
ScFOSとプロバイオティクスを製品に配合することで、プロバイオティクス菌株の生存と成長をサポートし、相乗効果をもたらします。ScFOSは様々な食品や飲食品に機能性成分として応用されています。乳製品、焼き菓子、シリアル、飲料、栄養補助食品など、幅広い製剤に配合することで、栄養プロファイルを強化し、その他の健康上のメリットを提供することができます。
科学的調査により、消化器系の健康と全体的な健康の維持における腸内細菌叢の重要な役割が明らかになっています。腸内細菌の組成と多様性は、消化、免疫機能、精神的健康など、人間の健康の様々な側面に影響を与えます。プレバイオティクス成分として、scFOSは有益な腸内細菌の増殖を選択的に促進し、腸内細菌叢の構成にプラスの影響を与え、消化器系の健康に貢献します。国立医学図書館によると、膨満感はscFOS摂取時に2.5g/日と5g/日の用量で有意に強くなったが、7.5g/日と10g/日の用量では認められません。
過敏性腸症候群(IBS)や炎症性腸疾患(IBD)のような消化器疾患は世界的に蔓延しつつあります。その結果、これらの症状を管理し、消化器系の健康を促進する飲食品に対する需要が高まっています。プレバイオティクス特性を持つScFOSは、症状を緩和し、腸の機能を改善する可能性のある自然なソリューションを提供します。健康全般における腸の健康の重要性は、近年大きな注目を集めています。消費者は、健康な腸内マイクロバイオームと、消化、免疫機能、さらには精神的な幸福など、健康のさまざまな側面との関連性をより意識するようになっています。
COVID-19分析には、COVID前シナリオ、COVIDシナリオ、COVID後シナリオに加え、価格力学(COVID前シナリオと比較したパンデミック中およびパンデミック後の価格変動を含む)、需給スペクトラム(取引制限、封鎖、およびその後の問題による需給の変化)、政府の取り組み(政府機関による市場、セクター、業界を活性化させる取り組み)、メーカーの戦略的取り組み(COVID問題を緩和するためにメーカーが行ったことをここで取り上げる)が含まれます。
The Global Short-Chain Fructooligosaccharides (scFOS) market reached US$ 570.5 million in 2022 and is projected to witness lucrative growth by reaching up to US$ 1,231.8 million by 2030. The market is growing at a CAGR of 10.1% during the forecast period 2023-2030.
Digestive health has become a key area of focus for consumers, with increasing recognition of the role of gut microbiota in overall wellness. ScFOS, as prebiotics, nourish and promote the growth of beneficial gut bacteria, supporting a healthy gut microbiota composition. ScFOS can act as a source of nutrients for probiotics, the beneficial bacteria that promote gut health.
Combining scFOS with probiotics in products can provide synergistic benefits by supporting the survival and growth of probiotic strains. ScFOS find applications as functional ingredients in various food and beverage products. They can be incorporated into a wide range of formulations, including dairy products, baked goods, cereals, beverages, and nutritional supplements, to enhance their nutritional profile and provide additional health benefits.
Scientific research has uncovered the critical role of gut microbiota in maintaining digestive health and overall well-being. The composition and diversity of gut bacteria influence various aspects of human health, including digestion, immune function, and mental health. As a prebiotic ingredient, scFOS selectively promotes the growth of beneficial gut bacteria, which can positively impact the gut microbiota composition and contribute to digestive health. According to the National Library of Medicine, Bloating was significantly more intense during scFOS ingestion at doses of 2.5 and 5 g/d, but not at doses of 7.5 and 10 g/d.
Digestive disorders such as irritable bowel syndrome (IBS) and inflammatory bowel disease (IBD) are becoming more prevalent globally. As a result, there is a growing demand for food and beverage products that can help manage these conditions and promote digestive wellness. ScFOS, with its prebiotic properties, offers a natural solution that can potentially alleviate symptoms and improve gut function. The importance of gut health in overall wellness has gained significant attention in recent years. Consumers are becoming more aware of the link between a healthy gut microbiome and various aspects of health, including digestion, immune function, and even mental well-being.
The COVID-19 Analysis includes Pre-COVID Scenario, COVID Scenario, and Post-COVID Scenario along with Pricing Dynamics (Including pricing change during and post-pandemic comparing it to pre-COVID scenarios), Demand-Supply Spectrum (Shift in demand and supply owing to trading restrictions, lockdown, and subsequent issues), Government Initiatives (Initiatives to revive market, sector or Industry by Government Bodies) and Manufacturers Strategic Initiatives (What manufacturers did to mitigate the COVID issues will be covered here).
The global short-chain fructooligosaccharides market is segmented based on source, form, application, and region.
Short-chain fructooligosaccharides (scFOS) find extensive applications in the food and beverages industry. They are used as functional ingredients in various products, including dairy products, baked goods, cereals, beverages, and nutritional supplements. The versatility of scFOS and their compatibility with different food matrices make them popular among food and beverage manufacturers.
There is a growing consumer demand for functional foods and beverages that offer additional health benefits beyond basic nutrition. Functional ingredients like scFOS, known for their prebiotic properties and potential health benefits, are highly sought after by health-conscious consumers. The food and beverages segment responds to this demand by incorporating scFOS into its product formulations.
North America has experienced a growing demand for functional ingredients in the food and beverage industry. Consumers are increasingly seeking products that offer additional health benefits beyond basic nutrition. This demand has driven the incorporation of functional ingredients like scFOS into a wide range of food and beverage products. The North American population has shown an increased focus on health and wellness.
Consumers are becoming more aware of the importance of maintaining a healthy diet and lifestyle. As a result, there is a growing interest in products that support digestive health, weight management, and overall well-being. ScFOS, known for its prebiotic properties and potential health benefits, align with this health-conscious trend.
The major global players include: the Short-chain Fructooligosaccharides (scFOS) market are Beneo-Orafti, Jarrow Formulas Inc., Sensus B.V., Tata Sons Private Limited, Galam, Cosucra Groupe Warcoing SA, Tereos, CJ Cheiljedang Corp., Ingredion, and Meiji Food Materia Co., Ltd.
The global short-chain fructooligosaccharides market report would provide approximately 61 tables, 57 figures, and 200 pages.
LIST NOT EXHAUSTIVE